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Abstract. In this study, we develop a novel photoacoustic imaging technique based on gold nanorods (AuNRs)
for quantitatively monitoring focused-ultrasound (FUS) induced blood-brain barrier (BBB) opening in a rat
model in vivo. This study takes advantage of the strong near-infrared absorption (peak at ∼800 nm) of AuNRs
and the extravasation tendency from BBB opening foci due to their nano-scale size to passively label the BBB
disruption area. Experimental results show that AuNR contrast-enhanced photoacoustic microscopy (PAM) success-
fully reveals the spatial distribution and temporal response of BBB disruption area in the rat brains. The quantitative
measurement of contrast enhancement has potential to estimate the local concentration of AuNRs and even the
dosage of therapeutic molecules when AuNRs are further used as nano-carrier for drug delivery or photothermal
therapy. The photoacoustic results also provide complementary information to MRI, being helpful to discover more
details about FUS induced BBB opening in small animal models. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE).
[DOI: 10.1117/1.JBO.17.6.061222]
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1 Introduction
The blood-brain barrier (BBB) is a selectively permeable inter-
face that constrains the transmission of substance from cerebral
blood vessels to brain tissues. It is mainly composed of tightly
attached endothelial cells, a layer of basement membrane, and
the end-feet of astrocyte cells [as illustrated in Fig. 1(a)]. When
protecting the central nervous system (CNS) from external
attacks, the BBB also massively limits the penetration of drugs
for cerebral diseases. A recent study even indicates that only
5% of over 7,000 drugs for primarily treating depression, schi-
zophrenia, and insomnia can affect the CNS.1 To overcome this
difficulty, nanoparticles—a novel drug delivery system—have
long been noticed for penetrating the BBB.2 In this regard,
nanotechnology hides the original characteristics of drugs and
reduces their leaching in brain tissues3 to achieve a more effi-
cient and safer drug delivery.
With the involution of focused ultrasound (FUS), which has
recently been demonstrated to be able to disrupt BBB locally,
temporarily, and invasively.4–8 Nanoparticles offer the feasibility
of image-guided local drug delivery for the treatment of CNS
diseases such as Alzheimer’s disease,9 brain tumor,10 epilepsy,
and Parkinson’s disease.11 In addition, the acoustic intensity
needed to disrupt BBB can be reduced by the incorporation
of microbubbles.4 The administration of microbubbles ensures
minimally thermal damage of brain tissue caused by FUS and
consistently focal BBB opening. The current major imaging
modality to identify BBB disruption is contrast-enhanced mag-
netic resonance imaging (MRI); however, its temporal and spa-
tial resolution may still not be good enough to monitor some
temporal and localized responses of BBB during the disruption
such as transient ischemic attack6 and brain hemorrhage.12 Since
there is a trade-off between the spatial resolution and scanning
time of MRI, it will be a challenge for MRI to real-time monitor
the BBB opening with the target well resolved in space. So
imaging modalities offering different contrast with more accu-
rate positioning and shorter scanning time in the monitoring of
BBB opening are now desired to provide complementary
information to the MRI results.
Photoacoustic imaging (PAI)13–15 is a novel imaging modal-
ity, which combines excellent optical absorption and good
ultrasound spatial resolution for biomedical imaging and also
potentially owns real-time imaging capability. Thermal expan-
sion of optical absorbers heated by laser with particular wave-
length will lead to an acoustic radiation called photoacoustic
wave, then the variation of pressure will be detected by an ultra-
sonic transducer to form a photoacoustic image. With various
kinds of gold nanoparticles16 as contrast agents such as nano-
shells,17 nanocages,18 and nanorods,19 PAI provides a unique
opportunity to detect blood-vessel leakage. As a member of
PAI, photoacoustic microscopy (PAM)14,20,21 has been proven
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a promising tool for micro-vascular imaging in small animal
models.22–24 Gold-nanorods (AuNRs) are rod-shaped gold nano-
particles with excellent biological compatibility due to their gold
surface. They have been applied to photothermal therapy of squa-
mous cell carcinoma in mice25 and have also been used as a nano-
carrier for remote control of localized gene expression.26 The
optical absorption spectrum of AuNRs is dominated by the long-
itudinal mode of two different surface plasma resonances (SPR),
while the transverse component is extremely weak. The strong
absorption spectral band caused by longitudinal SPR can be
tuned from visible to near-infrared (NIR) range by changing
the aspect ratio of AuNRs. When shifting the absorption peak
of AuNRs to ca. 800 nm,16 which avoids the strong absorption
of blood, one may then obtain a good contrast agent for PAI.
In this study, we verify the feasibility of AuNR contrast-
enhanced PAM technique for monitoring FUS-induced BBB
opening in a rat model in vivo. AuNRs were chosen as a contrast
agent because of its extravasation tendency at the FUS-induced
BBB opening foci resulting from the nano-scale size. The PAM
was employed to monitor on the distribution of administered
AuNRs during and after FUS-induced BBB opening. After the
BBB was disrupted by FUS, injected AuNRs would passively
accumulate in the targeted brain and selectively be excited by
a tunable laser source. Then the proposed contrast-enhanced
PAM was used to monitor the contrast enhancement caused by
AuNRs in brains responding to the changes of BBB permeability.
2 Materials and Methods
2.1 Experimental Setup
Figure 1(a) shows the whole procedure of FUS-induced BBB
opening and the PAM monitoring. First, a high-intensity FUS
transducer (diameter: 60 mm, radius of curvature: 80 mm,
frequency: 1.5 MHz, electric-to-acoustic efficiency: 70%, Ima-
sonics) driven by the signal generated from an arbitrary function
generator (33220A, Agilent) was used to induce the BBB open-
ing in a rat model after the pre-scan of the brain. The FUS exci-
tation signal was amplified by a radiofrequency power amplifier
(150A100B, Amplifier Research) and monitored by a power
meter (Model 4421, Bird) before feeding into the FUS transdu-
cer. During the sonication, the rats were immobilized under a
water tank with their head tightly attached to the thin-film win-
dow. The ultrasound contrast agents (SonoVue, Bracco) were
intravenously injected into the rats to facilitate acoustic cavita-
tion. Since a wide sonication area is also helpful to increase the
probability of BBB opening, ultrasound energy was then
sequentially delivered into the rat brains at three spots separated
within the distance of 2 mm along the longitudinal direction of
brains, and the focus was placed at 3 mm under the surface of
brains. For each spot, burst-mode ultrasound was used with a
burst length of 10 ms, a PRF of 1 Hz, duration of 30 sec,
and input electric power of 1 W corresponding to acoustic pres-
sure of 0.48 MPa for safe BBB opening12 avoiding hemorrhage.
Second, the injection of AuNRs (9.4 nM and 0.5 ml) fol-
lowed the FUS sonication. The AuNRs used for this study in
Fig. 1(b) were fabricated by the electrochemical method.27
By tuning the averaged dimensions of AuNRs to 40 nm by
10 nm, their absorption peak was shifted to 800-nm wavelength.
In addition, polyethylene glycol (PEG) was coated to the surface
of AuNRs to increase their biocompatibility, stealth effect to the
immune system, and consequently the circulation time in blood
stream. After a tenfold dilution, the peak absorbance of AuNR
suspension was measured as 2 [Fig. 1(c)] by a spectrophot-
ometer (USB4000-VIS-NIR, Ocean Optics), and that repre-
sented a maximum absorbance of 20 for the undiluted one.
Fig. 1 (a) Experimental procedure of FUS-induced BBB opening and the proposed contrast-enhanced PAM monitoring in a rat model. The injected
AuNRs would leak and accumulate at the BBB opening foci after the FUS sonication. (b) TEM image of AuNRs. (c) Absorption spectra of diluted AuNR
solution and Evans blue with three different concentrations.
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In the last step, dark-field confocal PAM cooperating with
AuNRs was employed for monitoring BBB opening, as
shown in Fig. 2. A tunable laser system provided laser pulses
with 10-Hz pulse-repetition frequency (PRF), 6.5-ns pulse
width, and 800-nm wavelength. In addition to avoiding the
strong interference from blood, 800-nm wavelength is also an
isosbestic point in absorption spectrum of hemoglobin that
we can ignore the effects of blood oxygenation on PAM mea-
surements. The laser light was aligned to be confocal with a
25-MHz focused ultrasonic transducer (−6 dB fractional band-
width: 55%, focal length: 13 mm, v324, Olympus) at 3 mm
under the surface of rat brains. The photoacoustic signals re-
ceived by the transducer were preamplified by a low-noise am-
plifier (AU-3A-0110, Miteq) and an ultrasonic pulser/receiver
(5073PR, Olympus), lowpass filtered (BLP-50þ, Mini-Circuits),
digitized by a 14-bit A/D card (CompuScope 14200, GaGe), and
then stored in the PC. A two-dimensional (2-D) raster scanning
covering 8 × 5 mm2 was performed by a set of piezoelectric
motors (HR8 Ultrasonic Motor, Nanomotion) with a step of
120 μm in each direction. The 25-MHz ultrasonic transducer
offered −6 dB resolutions of 68 μm and 171 μm in axial and
lateral directions,23,24 respectively. The resolutions are defined
by the −6 dBwidth of the lateral and axial profiles of an imaged
6-μm carbon fiber. The 2-D PAM raster scanning took about
20 min when a four-time signal averaging was applied on
each single scan line to increase the signal-to-noise ratio.
Note that for all the following photoacoustic images and quan-
titative analysis, envelope detection was performed by using
Hilbert transform.28
2.2 Animals Handling
Adult male rats (N ¼ 3) of Sprague Dawley strain with body
weight of about 300 g were used for in vivo animal experiments.
All experiments were performed in accordance with the regula-
tions of the Laboratory Animal Center of National Tsing Hua
University, Taiwan. The rats were initially anesthetized using
chlorohydrate (300 mg∕kg) through intraperitoneal (IP) injec-
tion before PAM monitoring. A craniotomy was performed
on the rats to reduce distortion of the FUS focal beam; moreover
it increased the energy delivery of ultrasound and laser. A cranial
window (8 × 5 mm2) was fashioned with a high-speed drill, and
a PE-50 catheter was placed in the jugular vein. The skull
defects were covered with saline-soaked gauze to prevent dehy-
dration until the pre-scan was applied. In order to avert photo-
acoustic interference from extravasated blood on the brain
surface, we endeavored to avoid hemorrhage during the craniot-
omy. The rats were subsequently anesthetized by isoflurane
gas anesthesia with a dose of 1% of pure oxygen at 1 L∕min
flow rate after the administration of AuNRs. The AuNR dosage
of 0.52 mg∕kg used in this study is much lower than the low-
toxicity dosage of 118 mg∕kg reported in the literature.29
During the scanning, the rats were immobilized by a custom
animal holder with its head attached to the thin film, and
warmed by a lamp and constant water temperature to keep
their vitality. The incident laser energy density at 800 nm is
∼1 mJ∕cm2, which is much smaller than the ANSI safety
limit30,31 of 30 mJ∕cm2, and a layer of acoustic gel was smeared
between the thin film and the brain to ensure good coupling of
the generated PAwaves. The rats were sacrificed after the PAM
monitoring for further histological confirmation.
3 Results and Discussions
To demonstrate the feasibility of AuNR contrast-enhanced PAM
for confirming the region of BBB opening spatially, PEGylated
AuNRs (9.4 nM and 0.5 ml) was injected into the rat via the
catheter after the sonication applied on the center of the
brain. Since physiological section is one of the most accurate
methods to confirm the distribution of BBB opening, Evans
blue (0.3% and 0.1 ml) was also injected to stain the brain tis-
sues around the BBB opening foci. Because the main absorption
region of Evans blue is below 700 nm [Fig. 1(c)], Evans blue can
hardly enhance contrast at 800 nm making it distinguishable
from AuNRs in PAM. Figure 3(a) and 3(b) show the photoa-
coustic image of the rat brain outside and inside the FUS soni-
cation area. The brightness of the photoacoustic images
represents the intensity of detected photoacoustic envelopes
in linear scale. Figure 3(b) shows that there is a local contrast
enhancement at the center of the brain caused by the high local
concentration of AuNRs, while there is no particular change in
Fig. 3(a). The distribution of contrast enhancement in photoa-
coustic images conforms to the frozen sections of the rat brain
stained by Evans blue in Fig. 3(c) and 3(d). The experimental
result indicates that AuNR-enhanced PAM can successfully
visualize the BBB opening region.
Then, to monitor the temporal response of BBB opening,
FUS was performed on the left side of the rat brain. AuNR
suspension (9.4 nM and 0.5 ml) was alone injected (i.e., with-
out Evans blue) in this case. Figure 4 shows the sequential
photoacoustic envelope images of the brain along the dotted
line within the cranial window in Fig. 4(a) in linear scale.
Figure 4(a) is the photograph of the brain surface captured
after the PA monitoring, and it shows that the sonicated brain
tissues cannot be distinguished from normal ones by naked
eyes. Figure 4(b) shows the pre-scan image used as a controlled
group. Figure 4(c)–4(f) show the photoacoustic images acquired
at 28, 51, 80, and 109 min after the FUS sonication respectively.
Figure 4(b) and 4(c) identify that an obvious contrast enhance-
ment was profiled in the designed focal path of the FUS after the
injection of AuNRs, while there were no observable contrast
enhancement in the right-brain as we expected. The enhanced
Fig. 2 Schematic diagram of dark-field confocal PAM system for in vivo
monitoring of FUS-induced BBB opening.
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photoacoustic signals in the left brain remained until the end of
the two-hour monitoring.
To more quantitatively analyze the time-dependent changes
in AuNRs leakage into the brain tissue, we sum the values of
photoacoustic envelopes within the regions of interest in the
brain at each acquiring time. Figure 5 shows the time-intensity
curves (TICs) and indicates that there is a rapid increase of 6 dB
within 30 min after the FUS sonication. TIC of the right-brain
reveals that there is no contrast enhancement in the normal cer-
ebral vessels because the AuNR suspension is diluted by the
blood to approximately 1.6% of the original. The effective
absorbance of AuNRs decreases to 0.32 in the blood stream
of the rats. According to the study of Nanopartz,32 about
90% extinction for AuNRs is caused by the absorption coeffi-
cient μa. Thus AuNRs contributes a negligible μa of∼0.66 cm−1
in the blood stream when being compared with the μa of blood,
which is ∼4 cm−1 at 800 nm.33 Therefore, the overall optical
absorption within the unsonicated area can be regarded as the
contribution from the blood. Despite the low concentration of
AuNRs in the blood stream, the leakage and accumulation of
AuNRs at the BBB opening foci increase the local concentration
of AuNRs, which means more optical absorbers in the photo-
acoustic sample volume. When considering the ideal situation
that the intensity of photoacoustic signal is proportional to
μa, the μa of locally accumulated AuNRs can be approximated
Fig. 3 Photoacoustic envelope images of the rat brain (a) outside and (b) inside the FUS sonication area. (c) and (d): Evans-blue stained frozen sections
corresponding to (a) and (b), respectively.
Fig. 4 (a) Photograph of the sonicated rat brain after two-hour PAM monitoring. (b), (c), (d), (e), and (f): Photoacoustic envelope images of the rat brain
acquired at pre-scan, 28, 51, 80, 109 min after the FUS sonication.
Fig. 5 Total value of photoacoustic envelopes in the left and right ROI
in the rat brain.
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to ∼4 cm−1 by comparing the signal intensity of accumulated
AuNRs to that of blood. Because μa is proportional to the con-
centration of the optical absorber, the μa increase of AuNRs
from 0.66 cm−1 in the blood stream to 4 cm−1 at the BBB open-
ing foci also indicates a ∼6.1-fold local increase in the concen-
tration of AuNRs at BBB opening foci, which leads to the
contrast enhancement of the left brain in Fig. 4. Although
the contrast enhancement in the TIC of left-brain decreases
slowly until the end of the monitoring, it does not draw back
to the baseline indicated by TIC of the right brain. The result
suggests that AuNRs may stick in the brain longer than two
hours. It verifies the feasibility of AuNRs for cerebral drug
delivery and also provides a unique opportunity to guide the
treatment of brain tumor by incorporating AuNR contrast-
enhanced PAM into photothermal therapy.
4 Conclusions
In this study, we verify the feasibility of AuNR contrast-
enhanced PAM for monitoring the BBB opening in a rat
model in vivo. The contrast enhancement is caused by the
high local concentration of AuNRs at BBB opening foci due
to the leakage and accumulation of AuNRs after the FUS soni-
cation. Experimental results show that AuNR contrast-enhanced
PAM successfully reveals the spatial distribution and temporal
responses of BBB disruption area in the rat brains. The quanti-
tative measurement of contrast enhancement has potential to
estimate the local concentration of AuNRs and even the dosage
of therapeutic molecules when AuNRs are further used as nano-
carriers for drug delivery or photothermal therapy.34,35 The
photoacoustic results also provide complementary information
to MRI, which is helpful to discover more details about BBB
opening in small animal models.
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